New pain shot could cut opioid use after back surgery
NCT ID NCT07171125
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study tests a new, long-lasting painkiller (liposomal bupivacaine) that works for up to 72 hours after spine surgery, compared to the standard 6-8 hour painkiller. About 204 adults having lower back surgery will be randomly assigned to receive one of the two painkillers. The goal is to see if the longer-lasting option reduces the need for strong opioid pain medicines and improves pain control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUMBAR DEGENERATIVE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Third Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study tests simple injection to ease C-Section pain
- Which nerve block eases shoulder surgery pain best?
- AI takes the guesswork out of anesthesia timing
- Root canal pain mystery solved: electronic devices vs X-Ray
- New study aims to ease pain after breast cancer surgery without strong drugs
- Spinal injection vs. nerve block: which eases chest surgery pain better?